News | March 11, 2023
IIT Kanpur and Reliance Life Sciences join forces to revolutionize gene therapy for hereditary eye diseases
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
For discovery or for standardization, Ayurveda colleges/institutes need to collaborate closely with Phytochemists, Pharmacologists, and Toxicologists from premier institutions
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
The AGE1.CR.pIX cell line is derived from primary cells of a duck embryo and was designed to comply with health authority guidelines
The hospital will have all the modern facilities like modular OT, state of the art medical equipment, labs, etc. It will have OPD and IPD services
The new project further expands the partner's long-term collaboration on new technologies for R&D
MVUs will provide diagnosis treatment, vaccination, artificial insemination, minor surgical interventions, audio-visual aids and extension services to farmers/animal owners at their doorstep in far flung areas.
Lumpi-ProVacind is used for the prophylactic immunization of animals against Lumpy Skin Disease, which illicit protection for about one year
The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
Subscribe To Our Newsletter & Stay Updated
